Science in The Marketplace: Acnotabs and The Food and Drug Administration  

Oleh:

Apple, Rima D.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Public Understanding of Science vol. 2 no. 1 (Jan. 1993), page 59-70.
Fulltext: 59PUS21.pdf (852.63KB)

Isi artikel

Though acne is not a life-threatening condition, it is a highly rm~ti~nallcyha rged one, particularly for teenagers. In the early 196% when the Pannett Company used medical and scientific claims to eonvince adolescents to purchase their product Acnotabs, their amazing advertising claims attracted the attention of the US Food and Drug Administration. Typically the Agency seized a product it considered mislabelled in terms of its ingredients or its efficacy; and most companies, not willing to face a potentially expensive light, did not object to the action. In effect, they allowed the courts to issue a condemnation order by default. The Pannett Company, however, resisted the FDA’s Seirure and decided to present their case for Acnotabs in court. The Company insisted that their tests had demonsIrated the usefulness of Acnotabs in treating the skin condition. The FDA claimed that there was no evidence for the effectiveness of Amotabs and. momver, that scientific and medical theory denied that the ingredients in Acnotabs would cure acne. The m r d s of this case provide a unique demonstration of how a layperson, a judge, evaluated wmp4ng delinitions of science and scientific proof.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali